+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 85Years
All Genders
ID07805785

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder Compared With Placebo in Adults With Progressive Pulmonary Fibrosis Using a Capsule-Based Dry Powder Inhaler

Led by Insmed Incorporated · Updated on 2026-11-02

800

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of once daily treatment with Treprostinil Palmitil Inhalation Powder TPIP compared with a placebo in adults with progressive pulmonary fibrosis PPF. This Phase 3 randomized, double-blind, placebo-controlled study aims to assess lung function and safety over a long period, focusing on patients with interstitial lung disease who have shown disease progression despite standard treatments. Participants will be randomly assigned to receive either TPIP or a matching placebo once daily for up to 104 weeks. The starting dose of TPIP is 80 micrograms and may be increased to the maximum tolerated dose of 1280 micrograms. Both treatments are inhaled using a capsule-based dry powder inhaler device. The study uses a parallel group design and includes a placebo comparator. During the study, participants will undergo regular assessments including lung function tests such as forced vital capacity FVC and diffusing capacity for carbon monoxide DLCO. Researchers will monitor clinical worsening events, acute exacerbations, symptom scores, plasma drug concentrations, and any adverse events for up to two years. The primary outcome is the change in absolute FVC from baseline to week 52. Participants will be closely monitored throughout the treatment period to evaluate efficacy and safety.

CONDITIONS

Brief Title

A Study to Assess the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Progressive Pulmonary Fibrosis (PPF)

Research Team

I

Insmed Medical Information

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here